# Bone Resorption, Osteoclastogenesis and Adalimumab

> **NCT00814866** · NA · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 28 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT00814866
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-09
- **Final completion:** 2011-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814866, "Bone Resorption, Osteoclastogenesis and Adalimumab". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00814866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*